Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised

array:22 ["pii" => "S0301054613002772" "issn" => "03010546" "doi" => "10.1016/j.aller.2013.08.003" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "567" "copyright" => "SEICAP" "copyrightAnyo" => "2013" "documento" => "article" "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2015;43:19-24" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 955 "formatos" => array:3 [ "EPUB" => 13 "HTML" => 550 "PDF" => 392 ] ] "itemSiguiente" => array:17 [ "pii" => "S0301054614000287" "issn" => "03010546" "doi" => "10.1016/j.aller.2013.10.006" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "592" "copyright" => "SEICAP" "documento" => "article" "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2015;43:25-31" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 808 "formatos" => array:3 [ "EPUB" => 9 "HTML" => 349 "PDF" => 450 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Original Article" "titulo" => "Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "25" "paginaFinal" => "31" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "N. Santos, A.M. Pereira, R. Silva, J. Torres da Costa, J.L. Plácido" "autores" => array:5 [ 0 => array:2 [ "nombre" => "N." "apellidos" => "Santos" ] 1 => array:2 [ "nombre" => "A.M." "apellidos" => "Pereira" ] 2 => array:2 [ "nombre" => "R." "apellidos" => "Silva" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Torres da Costa" ] 4 => array:2 [ "nombre" => "J.L." "apellidos" => "Plácido" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054614000287?idApp=UINPBA00004N" "url" => "/03010546/0000004300000001/v1_201501250943/S0301054614000287/v1_201501250943/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "S0301054614000172" "issn" => "03010546" "doi" => "10.1016/j.aller.2013.11.002" "estado" => "S300" "fechaPublicacion" => "2015-01-01" "aid" => "581" "copyright" => "SEICAP" "documento" => "article" "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2015;43:14-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1032 "formatos" => array:3 [ "EPUB" => 12 "HTML" => 699 "PDF" => 321 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "Original Article" "titulo" => "A human monoclonal anti-TNF alpha antibody (adalimumab) reduces airway inflammation and ameliorates lung histology in a murine model of acute asthma" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "14" "paginaFinal" => "18" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1385 "Ancho" => 2100 "Tamanyo" => 625015 ] ] "descripcion" => array:1 [ "en" => "(1a and 1b) Normal alveoli and bronchi (control group), H&E ×40 and ×100. (2a) Peri-bronchiolar and perivascular mix inflammation (asthma group), H&E ×40. (2b) Thickened alveolar walls with inflammation (asthma group), H&E ×100. (3a) The lung parenchyma without inflammation (adalimumab-treated group), H&E ×40. (3b) Mild thickened alveolar septa (adalimumab-treated group), H&E ×100." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Catal, E. Mete, C. Tayman, E. Topal, A. Albayrak, H. Sert" "autores" => array:6 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Catal" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Mete" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Tayman" ] 3 => array:2 [ "nombre" => "E." "apellidos" => "Topal" ] 4 => array:2 [ "nombre" => "A." "apellidos" => "Albayrak" ] 5 => array:2 [ "nombre" => "H." "apellidos" => "Sert" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054614000172?idApp=UINPBA00004N" "url" => "/03010546/0000004300000001/v1_201501250943/S0301054614000172/v1_201501250943/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "Original Article" "titulo" => "Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "19" "paginaFinal" => "24" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Y.H. Nam, M.R. Park, H.J. Nam, S.K. Lee, K.H. Kim, M.S. Roh, S.-J. Um, C.-H. Son" "autores" => array:8 [ 0 => array:3 [ "nombre" => "Y.H." "apellidos" => "Nam" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "M.R." "apellidos" => "Park" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "H.J." "apellidos" => "Nam" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] ] ] 3 => array:4 [ "nombre" => "S.K." "apellidos" => "Lee" "email" => array:1 [ 0 => "skleeai@dau.ac.kr" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 4 => array:3 [ "nombre" => "K.H." "apellidos" => "Kim" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] ] ] 5 => array:3 [ "nombre" => "M.S." "apellidos" => "Roh" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "d" "identificador" => "aff0020" ] ] ] 6 => array:3 [ "nombre" => "S.-J." "apellidos" => "Um" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 7 => array:3 [ "nombre" => "C.-H." "apellidos" => "Son" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Republic of Korea" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Pharmacy, Dong-A University Hospital, Busan, Republic of Korea" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Department of Pathology, College of Medicine, Dong-A University, Busan, Republic of Korea" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1141 "Ancho" => 1706 "Tamanyo" => 93573 ] ] "descripcion" => array:1 [ "en" => "Frequency of causative drugs of the study subjects." ] ] ] "textoCompleto" => "IntroductionDrug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a serious drug-induced adverse reaction with a relatively long latency period. The major clinical manifestations are fever, skin rash, and the involvement of several internal organs. Various names have been used to describe this single disease<a class="elsevierStyleCrossRefs" href="#bib0005">1–5</a>; this reflects the difficulties in defining the disorder and in clarifying its diagnostic criteria. Recently, the European Registry of Severe Cutaneous Adverse Reactions (RegiSCAR), a study group dedicated to investigating such reactions, has introduced the term hypersensitivity syndrome (HSS)/DRESS.<a class="elsevierStyleCrossRef" href="#bib0030">6</a> We consider HSS/DRESS to be more compatible, because this term includes elements of the pathogenesis, aetiology and clinical features.Originally, HSS/DRESS was first described in subjects who had been prescribed the anticonvulsant, phenytoin.<a class="elsevierStyleCrossRef" href="#bib0035">7</a> Other drugs which have been well known as causes include carbamazepine, allopurinol, sulfasalazine, phenobarbital, lamotrigine, and nevirapine.<a class="elsevierStyleCrossRef" href="#bib0025">5</a> Antibiotics,<a class="elsevierStyleCrossRef" href="#bib0030">6</a> non-steroidal anti-inflammatory drugs (NSAIDs),<a class="elsevierStyleCrossRef" href="#bib0030">6</a> and antituberculosis drugs<a class="elsevierStyleCrossRef" href="#bib0040">8</a> have been reported sporadically as causative drugs in the form of case reports. In addition, several new drugs have increasingly been reported as new causative agents for HSS/DRESS development.The other noteworthy feature of HSS/DRESS is a delayed onset usually 2–6 weeks after the initiation of drug therapy.<a class="elsevierStyleCrossRef" href="#bib0015">3</a> This finding can be compatible to many traditional causative drugs, which includes anticonvulsants and antituberculosis drugs.<a class="elsevierStyleCrossRefs" href="#bib0040">8,9</a> However, after careful review of case reports including those of antibiotics, there have been some causative drugs which have had a relatively short latency period of less than two weeks.<a class="elsevierStyleCrossRefs" href="#bib0045">9–14</a>Early withdrawal of the offending drug and administration of systemic corticosteroids (SCS) has been regarded as the most important step in the treatment of this disease.<a class="elsevierStyleCrossRef" href="#bib0075">15</a> More than 50% of study subjects were treated with SCS.<a class="elsevierStyleCrossRefs" href="#bib0080">16–19</a> However, randomised controlled trials are lacking, and whether SCS should be administered remains controversial.<a class="elsevierStyleCrossRef" href="#bib0075">15</a>We report clinical features of 45 subjects with HSS/DRESS in a single tertiary referral centre for two years, in which we describe the characteristics of causative agents, including latency period and clinical outcomes.Materials and methodsSubjectsWe conducted a retrospective analysis of prospectively collected data of 45 patients with HSS/DRESS syndrome, who were diagnosed between September 2009 and August 2011 in a tertiary referral centre. The clinical characteristics and courses of the patients were evaluated. This study was approved by the institutional review board of Dong-A University Hospital.Diagnostic criteriaPatients with HSS/DRESS were defined as described previously,<a class="elsevierStyleCrossRef" href="#bib0045">9</a> which was modified from other reports.<a class="elsevierStyleCrossRefs" href="#bib0010">2,20,21</a> This included: acute skin rash; fever of more than 38°C in a patient after taking a specific drug; at least one of the following internal organ abnormalities: lymphadenopathy at a minimum of two sites, hepatitis, nephritis, and/or pneumonitis, haematological abnormalities with eosinophilia (defined as more than 10% of total white blood cells or over 500cells/¿L), the presence of atypical lymphocytes, thrombocytopenia and/or leucopoenia. The involvement of the liver and kidney was defined by a twofold increase of liver enzymes over the normal value, and the new onset of an abnormal urinalysis with haematuria and/or proteinuria, an increasing serum creatinine above the normal range and a deterioration of pre-existing chronic renal insufficiency. Pulmonary involvement was considered when abnormal findings on chest radiographs were presented with either an increased sputum eosinophil count, improvement with SCS, or spontaneously. Central nervous system (CNS) involvement was considered when abnormal mental status was combined with radiological abnormalities in magnetic resonance imaging (MRI) and improvement after treatment with SCS. Additionally, we incorporated the RegiSCAR's<a class="elsevierStyleCrossRef" href="#bib0030">6</a> scoring system to grade HSS/DRESS cases as “no”, “possible”, “probable”, or “definite”.Cases of typical manifestations of Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) were excluded. Culprit drugs were determined by reviewing medication histories and clinical courses which showed improvements of skin rash and other systemic symptoms after discontinuation of the suspected drug.<a class="elsevierStyleCrossRef" href="#bib0110">22</a>Laboratory studiesComplete blood cell counts, serum biochemistry including liver and renal function tests, and urinalyses were performed. Serological tests for autoimmune antibodies such as antinuclear antibodies and anti-DNA antibodies, and several viral antibodies, including herpes simplex virus, cytomegalovirus, Epstein–Barr virus, HIV, and hepatitis A, B, and C viruses, were performed in order to rule out other autoimmune or viral diseases.Statistical analysesQuantitative and qualitative results are given by the means±SD and absolute numbers or frequencies, respectively. Descriptive statistics were performed using SPSS software (ver. 15.0; SPSS Inc., Chicago, IL, USA). We used laboratory values that were the highest values during the clinical course. Comparisons of various laboratory results were performed using the Mann–Whitney U and Kruskal–Wallis tests. Correlations between various clinical parameters were evaluated with the Pearson's correlation coefficient. P values<0.05 were considered to indicate statistical significance.ResultsClinical characteristics of study subjectsA total of 45 patients (19 males) who were diagnosed as having HSS/DRESS were included in this study. The mean age of the patients was 57.6±15.7 years (range, 26–86) (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Among 45 study patients 26 (57.8%) were referred from adjacent primary or secondary care hospitals. Twenty-eight patients (62.2%) were treated in the department of internal medicine and others were consulted from various surgical departments. The mean point according to RegiSCAR criteria was 4.4±1.36 points (range, 2–7) (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Subjects were classified as definite 13 (28.9%), probable 19 (42.2%), and possible 13 (28.9%) HSS/DRESS cases, respectively, and none of the subjects were compatible with “no”.<elsevierMultimedia ident="tbl0005"></elsevierMultimedia>Causative drugsThe most common causative drug group was antibiotics (n=13, 28.9%), followed by anticonvulsants (n=12, 26.7%), antituberculosis drugs (n=6, 13.3%), NSAIDs (n=4, 8.9%), undetermined (n=4, 8.9%), allopurinol (n=3, 6.7%) and others (n=3, 6.7%) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Causative antibiotics included cephalosporins, penicillins, moxifloxacin and vancomycin. Anticonvulsants included carbamazepine, phenobarbital, phenytoin, lamotrigine and topiramate. NSAIDs were diclofenac and celecoxib (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Antituberculosis drugs were isoniazid, rifampin, ethambutol, pyrazinamide (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>). Four cases were classified as undetermined due to the concomitant use of multiple drugs, while the remaining three cases were classified as “others” due to the use of anti-cancer, iron-chelating and proton-pump inhibitors (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>).<elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0020"></elsevierMultimedia>Latency periodThe latency period between the administration of causative drugs and the development of the manifestation of HSS/DRESS ranged from 2 to 120 days, with a mean of 20.2±24.3 days (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). The antituberculosis group had the longest latency period, 46.5±29.9 days (range, 24–100 days), followed by anticonvulsants with 31.1±31.2 days (range, 5–120 days). The latency period for antibiotics was 7.8±8.0 days (range, 2–28 days). A statistical significance was noted between anticonvulsants and antibiotics, as well as antituberculosis and antibiotics (p<0.05, respectively) (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).<elsevierMultimedia ident="fig0010"></elsevierMultimedia>Laboratory resultsHaematological abnormalities were found to include eosinophilia in 35 patients (77.8%), in addition to atypical lymphocytosis (n=16, 35.6%) and thrombocytopenia (n=7, 15.6%). All patients had involvement of at least one internal organ. Liver was the most frequently involved organ (n=39, 86.7%), followed by kidney (n=8, 17.8%), lung (n=4, 8.9%) and CNS (n=1, 2.3%) (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). None of the patients had positive findings for autoimmune antibodies or IgM antibodies to viruses.Treatment outcomeThirty-five patients (77.8%) were treated conservatively with topical steroids and antihistamines, while 10 patients (22.2%) were treated with SCS. The mean±SD time of admission in patients with SCS was 46.0±30.1 days (range, 11–111 days), and 18.4±11.7 days (range, 3–54 days) in patients with conservative treatment. Statistically significant differences were noted between the two groups (p<0.05). Most of the patients showed good clinical outcomes. Forty-three patients (95.6%) recovered completely. However, one patient died due to sepsis arising from long-term high-dose SCS treatment, and another patient had progressive hepatic failure, and was referred to another hospital in a remote region.DiscussionThis study is a retrospective analysis of prospectively collected data of 45 patients with HSS/DRESS in a tertiary referral hospital over a period of two years. The prevalence of HSS/DRESS was more common than had been generally recognised, and the causative drugs were quite variable. In particular, antibiotics and NSAIDs as well as antituberculosis drugs appeared to be major causes of HSS/DRESS. Antibiotics showed relatively short incubation periods (less than two weeks), and seemingly better clinical courses. Most of the study subjects (95.6%) showed better clinical outcomes than had been expected.The estimated incidence of HSS/DRESS was 1 in 1000–10,000 drug exposures.<a class="elsevierStyleCrossRef" href="#bib0115">23</a> In a referral centre hospital, the prevalence was reported approximately as 6–8 patients per year.(<a class="elsevierStyleCrossRefs" href="#bib0045">9,16,17,19</a>) The incidence of HSS/DRESS in this study was relatively high, at 45 patients during a two-year period in one tertiary referral centre. We believe that several factors have contributed to our findings. First, we implemented an adverse drug reaction surveillance system in our hospital, by which anyone involved in patient care was able to report any adverse drug reaction through a computerised communication system to a surveillance centre. Two medical doctors and one pharmacist evaluated adverse drug reactions and attempted to identify the causative drugs with an authorised algorithm. Second, any adverse drug reactions were usually followed up for some time until the patient showed an improvement. Some reactions were initially regarded as simple exanthematous drug eruptions, but conditions that progressed were ultimately diagnosed as HSS/DRESS, especially among the antibiotics group. Other reactions were defined initially as simple drug eruptions by doctors who were not familiar with HSS/DRESS, but were ultimately defined as HSS/DRESS. Finally, these data were collected from a tertiary referral centre located in the south-eastern part of South Korea, serving a region of more than three million inhabitants. More than 50% of study subjects were referred from primary or secondary care hospitals. These factors may explain the higher incidence in this study compared to previously published studies.<a class="elsevierStyleCrossRefs" href="#bib0045">9,16,17,19</a>One prominent result of this study was the finding that the most common causative drug group of HSS/DRESS was antibiotics, recognised as the causative agent for 13 patients (28.9%). This figure was relatively higher than a recent retrospective study which identified antibiotics as being the causative agent in 6 of 60 patients (10%).<a class="elsevierStyleCrossRef" href="#bib0095">19</a> This result may have originated from the misconception that HSS/DRESS could develop after the administration of anticonvulsants and allopurinol, and that HSS/DRESS caused by antibiotics showed a relatively milder course than any other causative drugs. Furthermore, incorrect diagnosis as a simple drug eruption by doctors who were not familiar with HSS/DRESS have also likely played a role in prior studies which have observed lower numbers of HSS/DRESS due to antibiotics.We think traditional culprit drugs, for example anticonvulsants and allopurinol, have higher risk than other drugs. However, our results also postulated that non-traditional causative drugs, for example antibiotics, antituberculosis and NSAIDs can cause HSS/DRESS. More attention should be paid to these non-traditional causative drugs, as new causative drugs of HSS/DRESS.A delayed onset of symptoms by 2–6 weeks after the initiation of the causative drug is a feature of HSS/DRESS.<a class="elsevierStyleCrossRef" href="#bib0015">3</a> In this study, the incubation time of the antibiotics group showed a significantly shorter duration than that of the anticonvulsants or antituberculosis group (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>). This phenomenon can be found in other reports of HSS/DRESS caused by antibiotics.<a class="elsevierStyleCrossRefs" href="#bib0045">9–14</a> We cannot explain this finding accurately, but it is likely that this occurs due to different drug metabolisms and variable individual sensitivity to metabolites of antibiotics. It is possible that a long latency period is adequate for some drugs, especially anticonvulsants. We believe that latency periods may be variable according to each culprit drug.At present, HSS/DRESS is generally treated with moderate- or high-dose SCS, but response may be suboptimal and can result in a prolonged exposure to SCS.<a class="elsevierStyleCrossRef" href="#bib0090">18</a> A recent retrospective analysis showed that 75% of study subjects were treated with SCS, and that the death rate was 10%.<a class="elsevierStyleCrossRef" href="#bib0095">19</a> In this study, SCS was administered to only 10 patients (22.0%), and the remaining 35 patients (77.8%) were treated conservatively without SCS. Furthermore, the proportion of complete recovery was 95.6%, and seemed higher than that of previous reports. A significant difference was noted in the number of admission days of SCS treated and conservatively treated group. However, the data were insufficient for direct comparison with previous published results, because there was a discrepancy in the composition of study patients, as well as in the culprit drugs.This study has several limitations. First, the culprit drugs were determined based on subjective clinical decisions, and not with objective methods such as lymphocyte toxicity assay or LTT. Second, evaluations to find out the association between viral reactivation and HSS/DRESS development should have been performed but were not.In conclusion, drugs associated with HSS/DRESS were variable, and attention should be paid to many new causative drugs, especially antibiotics and NSAIDs. HSS/DRESS was not more uncommon than generally recognised, and most patients with this disease showed better clinical outcomes than might have been generally expected based on previous findings.Ethical disclosuresPatients’ data protectionConfidentiality of data. The authors declare that they have followed the protocols of their work centre on the publication of patient data and that all the patients included in the study have received sufficient information and have given their informed consent in writing to participate in that study.Right to privacy and informed consentThe authors have obtained the informed consent of the patients and/or subjects mentioned in the article. The author for correspondence is in possession of this document.Protection of human subjects and animals in researchThe authors declare that no experiments were performed on humans or animals for this investigation.Conflict of interestAll authors have no conflicts of interest in this study. The authors alone are responsible for content and the writing of the paper." "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:2 [ "identificador" => "xres414307" "titulo" => array:5 [ 0 => "Abstract" 1 => "Background" 2 => "Methods" 3 => "Results" 4 => "Conclusions" ] ] 1 => array:2 [ "identificador" => "xpalclavsec389947" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:3 [ "identificador" => "sec0010" "titulo" => "Materials and methods" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Subjects" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Diagnostic criteria" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Laboratory studies" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Statistical analyses" ] ] ] 4 => array:3 [ "identificador" => "sec0035" "titulo" => "Results" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0040" "titulo" => "Clinical characteristics of study subjects" ] 1 => array:2 [ "identificador" => "sec0045" "titulo" => "Causative drugs" ] 2 => array:2 [ "identificador" => "sec0050" "titulo" => "Latency period" ] 3 => array:2 [ "identificador" => "sec0055" "titulo" => "Laboratory results" ] 4 => array:2 [ "identificador" => "sec0060" "titulo" => "Treatment outcome" ] ] ] 5 => array:2 [ "identificador" => "sec0065" "titulo" => "Discussion" ] 6 => array:3 [ "identificador" => "sec0070" "titulo" => "Ethical disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0075" "titulo" => "Patients’ data protection" ] 1 => array:2 [ "identificador" => "sec0080" "titulo" => "Right to privacy and informed consent" ] 2 => array:2 [ "identificador" => "sec0085" "titulo" => "Protection of human subjects and animals in research" ] ] ] 7 => array:2 [ "identificador" => "sec0090" "titulo" => "Conflict of interest" ] 8 => array:2 [ "identificador" => "xack123025" "titulo" => "Acknowledgment" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2013-05-30" "fechaAceptado" => "2013-08-07" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec389947" "palabras" => array:3 [ 0 => "Anticonvulsants" 1 => "Drug hypersensitivity" 2 => "Eosinophilia" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "BackgroundDrug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare disease which can cause severe morbidity and mortality. The aim of this study is to evaluate the clinical manifestation and course of DRESS syndrome. MethodsWe conducted a retrospective analysis of prospectively collected data in 45 patients with DRESS syndrome diagnosed between September 2009 and August 2011. ResultsThe most common causative drug group was antibiotics (n=13, 28.9%), followed by anticonvulsants (n=12, 26.7%), antituberculosis drugs (n=6, 13.3%), non-steroidal anti-inflammatory drugs (n=4, 8.9%), undetermined agents (n=4, 8.9%), allopurinol (n=3, 6.7%), and others (n=3, 6.7%). The latency period ranged from 2 to 120 days, with a mean of 20.2±24.3 days. The longest latency period was noted for the antituberculosis drug group, at 46.5±29.9 days. Eosinophilia in peripheral blood examination was noted in 35 subjects (77.8%). Atypical lymphocytosis was noted in 16 patients (35.6%), and thrombocytopenia in seven patients (15.6%). Hepatic involvement was noted in 39 (86.7%) study patients, kidney in eight (17.8%), lung in four (8.9%), and central nervous system in one (2.3%). Systemic corticosteroids were administered to 10 patients (22.2%). Forty-three patients (95.6%) showed complete recovery, while two patients had poor outcomes. ConclusionsDRESS syndrome was not more uncommon than generally recognised. Antibiotics were the most frequently implicated drug group, followed by anticonvulsants. Most patients with this disease showed a better clinical outcome than that which had been generally expected." ] ] "multimedia" => array:6 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1141 "Ancho" => 1706 "Tamanyo" => 93573 ] ] "descripcion" => array:1 [ "en" => "Frequency of causative drugs of the study subjects." ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1156 "Ancho" => 1666 "Tamanyo" => 57694 ] ] "descripcion" => array:1 [ "en" => "Incubation days according to the causative drugs. There was a statistically significant difference between the anticonvulsants and antibiotics group (P<0.05), and among the antibiotics and antituberculosis groups (P<0.05) respectively." ] ] 2 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:3 [ "leyenda" => "GOT. aspartate aminotransferase; GPT, alanine aminotransferase; TB, total bilirubin; DB, direct bilirubin." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Characteristics \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">n=45 (% or range) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Sex, male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">19 (42.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Age (years)<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">57.6±15.7 (26, 86) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Admission (days)<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">24.5±20.6 (3, 111) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Incubation (days)<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20.2±24.3 (2, 120) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Eosinophils (cells/¿L)<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2566.0±3129.5 (62, 13,296) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Atypical lymphocytosis (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">16 (35.6) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Thrombocytopenia (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7 (15.6) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Hepatitis (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">39 (86.7) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">GOT<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">214.4±335.0 (12, 1831) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">GPT<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">224.1±290.4 (8, 1482) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">TB<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.6±3.3 (0.3, 18.0) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">DB<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.0±2.1 (0.1, 10.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Nephritis (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8 (17.8) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Pneumonitis (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4 (8.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Central nervous system (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1 (2.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Systemic corticosteroids use (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10 (22.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Recurrence (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5 (11.1) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Poor prognosis (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2 (4.4) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Diagnostic score<a class="elsevierStyleCrossRef" href="#tblfn0005">a</a>,<a class="elsevierStyleCrossRef" href="#tblfn0010">b</a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.4±1.4 (2, 7) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab646877.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "Data presented as mean±SD of 45 study patients." ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "Diagnostic score by RegiSCAR." ] ] ] "descripcion" => array:1 [ "en" => "Clinical characteristics of the study patients." ] ] 3 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "NSAIDs; non-steroidal anti-inflammatory drugs." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Group \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">n (%) \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Antibiotics \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">13 (28.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Cephalosporins \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 (15.6) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Ceftriaxone \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 (6.7) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Cefotaxime \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Ceftezol \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Cefaclor \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Flumarin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Penicillin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 (8.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Tazocin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (4.4) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Nafcillin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Amoxicillin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Moxifloxacin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Vancomycin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Anticonvulsants \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">12 (26.7) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Carbamazepine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 (8.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Phenobarbital \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 (6.7) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Phenytoin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (4.4) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Lamotrigine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (4.4) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Topiramate \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">NSAIDs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 (8.9) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Diclofenac \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 (6.7) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top">Celecoxib \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1(2.2) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab646874.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Causative drugs of antibiotics, anticonvulsant and NSAIDs groups." ] ] 4 => array:7 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "F, female; M, male." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Number of patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age/Sex \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Disease \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Drugs \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">71/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Urethral tuberculosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Isoniazid, rifampin, ethambutol \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">86/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pulmonary tuberculosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ethambutol, pyrazinamide \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">78/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pulmonary tuberculosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">isoniazid \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">45/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pulmonary tuberculosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Isoniazid, rifampin, pyrazinamide \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">69/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pulmonary tuberculosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rifampin, ethambutol \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">74/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pulmonary tuberculosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rifampin, ethambutol \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab646875.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Clinical characteristics of six patients who had antituberculosis drugs as culprit drugs." ] ] 5 => array:7 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "Numbers 1–4 include patients with undetermined causative drugs.F, female; M, male." "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Number of patients \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age/Sex \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Disease \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Drugs \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">65/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pneumonia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ceftriaxone, ibuprofen \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">43/M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Bronchitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ceftezol, dicofenac \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">70/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pneumonia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Cefixime, diclofenac \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">68/M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Pneumonia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Ceftriaxone, phenytoin \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">66/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Colon cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5-fluorouracil \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">38/M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Leukaemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Desferasiroxa \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">61/F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Peptic ulcer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Rabeprazolb \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab646876.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Clinical characteristics of four patients who had undetermined drugs, and three with other culprit drugs." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:23 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S.A. Walsh" 1 => "D. Creamer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2230.2010.03967.x" "Revista" => array:6 [ "tituloSerie" => "Clin Exp Dermatol" "fecha" => "2011" "volumen" => "36" "paginaInicial" => "6" "paginaFinal" => "11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21143513" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "T. Shiohara" 1 => "M. Iijima" 2 => "Z. Ikeazwa" 3 => "K. Hashimoto" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2007.07807.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2007" "volumen" => "156" "paginaInicial" => "1083" "paginaFinal" => "1084" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17381452" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H. Bocquet" 1 => "M. Bagot" 2 => "J.C. Roujeau" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Semin Cutan Med Surg" "fecha" => "1996" "volumen" => "5" "paginaInicial" => "250" "paginaFinal" => "257" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R.D. Sontheimer" 1 => "K.R. Houpt" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Dermatol" "fecha" => "1998" "volumen" => "134" "paginaInicial" => "874" "paginaFinal" => "876" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9681358" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The DRESS syndrome: a literature review" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Cacoub" 1 => "P. Musette" 2 => "V. Descamps" 3 => "O. Meyer" 4 => "C. Speirs" 5 => "L. Finzi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2011.01.017" "Revista" => array:6 [ "tituloSerie" => "Am J Med" "fecha" => "2011" "volumen" => "124" "paginaInicial" => "588" "paginaFinal" => "597" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21592453" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.H. Kardaun" 1 => "A. Sidoroff" 2 => "L. Valeyrie-Allanore" 3 => "S. Halevy" 4 => "B.B. Davidovici" 5 => "M. Mockenhaupt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2006.07704.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2007" "volumen" => "156" "paginaInicial" => "609" "paginaFinal" => "611" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17300272" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of epilepsy with sodium diphenyl hydantoine" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Coope" 1 => "R. Burrows" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "1940" "volumen" => "1" "paginaInicial" => "490" "paginaFinal" => "492" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2563853" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antituberculosis drug-induced drug rash with eosinophilia and systemic symptoms syndrome confirmed by patch testing" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.W. Lee" 1 => "N.B. Yoon" 2 => "S.M. Park" 3 => "S.M. Lee" 4 => "S.J. Um" 5 => "S.K. Lee" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Investig Allergol Clin Immunol" "fecha" => "2010" "volumen" => "20" "paginaInicial" => "620" "paginaFinal" => "632" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21314006" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical features of drug-induced hypersensitivity syndrome in 38 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.J. Um" 1 => "S.K. Lee" 2 => "Y.H. Kim" 3 => "K.H. Kim" 4 => "C.H. Son" 5 => "M.S. Roh" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Investig Allergol Clin Immunol" "fecha" => "2010" "volumen" => "20" "paginaInicial" => "556" "paginaFinal" => "562" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21313995" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Moxifloxacine-associated drug hypersensitivity syndrome with drug-induced hypersensitivity pneumonitis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.H. Son" 1 => "H.I. Kim" 2 => "K.N. Kim" 3 => "K.N. Lee" 4 => "C.U. Lee" 5 => "M.S. Roh" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Investig Allergol Clin Immunol" "fecha" => "2008" "volumen" => "18" "paginaInicial" => "72" "paginaFinal" => "73" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18361108" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lenezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Savard" 1 => "S. Desmeules" 2 => "J. Riopel" 3 => "M. Aqharazii" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.ajkd.2009.07.013" "Revista" => array:6 [ "tituloSerie" => "Am J Kidney Dis" "fecha" => "2009" "volumen" => "54" "paginaInicial" => "e17" "paginaFinal" => "e20" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19733945" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vancomycin-induced DRESS syndrome in a female patient" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Vauthey" 1 => "I. Uckay" 2 => "S. Abrassart" 3 => "L. Bernard" 4 => "M. Assal" 5 => "T. Ferry" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000142729" "Revista" => array:6 [ "tituloSerie" => "Pharmacology" "fecha" => "2008" "volumen" => "82" "paginaInicial" => "138" "paginaFinal" => "141" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18607115" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R. Tamagawa-Mineoka" 1 => "N. Katoh" 2 => "T. Nara" 3 => "Y. Nishimura" 4 => "S. Yamato" 5 => "S. Kishinoto" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-4632.2007.03255.x" "Revista" => array:6 [ "tituloSerie" => "Int J Dermatol" "fecha" => "2007" "volumen" => "46" "paginaInicial" => "654" "paginaFinal" => "655" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17550572" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A case of cephalosporin-induced DRESS (drug rash with eosinophilia and systemic symptoms) syndrome with acute renal failure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.M. Ahn" 1 => "J.H. Moon" 2 => "J.G. Moon" 3 => "K.M. Lee" 4 => "J.H. Lee" 5 => "C.S. Hong" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Korean J Asthma Allergy Clin Immunol" "fecha" => "2005" "volumen" => "25" "paginaInicial" => "69" "paginaFinal" => "72" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Tas" 1 => "T. Simonart" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "69956" "Revista" => array:6 [ "tituloSerie" => "Dermatology" "fecha" => "2003" "volumen" => "206" "paginaInicial" => "353" "paginaFinal" => "356" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12771485" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.C. Chiou" 1 => "L.C. Yang" 2 => "S.I. Hung" 3 => "Y.C. Chang" 4 => "T.T. Kuo" 5 => "Y.C. Chang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2008.02585.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2008" "volumen" => "22" "paginaInicial" => "1044" "paginaFinal" => "1049" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18627428" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Ben m’rad" 1 => "S. Leclerc-Mercier" 2 => "P. Blanche" 3 => "N. Franck" 4 => "F. Rozenberg" 5 => "Y. Fulla" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Medicine (Baltimore)" "fecha" => "2009" "volumen" => "88" "paginaInicial" => "131" "paginaFinal" => "140" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Eshki" 1 => "L. Allanore" 2 => "P. Musette" 3 => "B. Milpied" 4 => "A. Grange" 5 => "J.C. Guillaume" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archderm.145.1.67" "Revista" => array:6 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2009" "volumen" => "145" "paginaInicial" => "67" "paginaFinal" => "72" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19153346" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Y.C. Chen" 1 => "H.C. Chiu" 2 => "C.Y. Chu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archdermatol.2010.198" "Revista" => array:6 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2010" "volumen" => "146" "paginaInicial" => "1373" "paginaFinal" => "1379" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20713773" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical heterogeneity of drug hypersensitivity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.C. Roujeau" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.tox.2004.12.022" "Revista" => array:6 [ "tituloSerie" => "Toxicology" "fecha" => "2005" "volumen" => "209" "paginaInicial" => "123" "paginaFinal" => "129" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15767024" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Allopurinol hypersensitivity syndrome: a review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "F. Arellano" 1 => "J.A. Sacristan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Pharmacother" "fecha" => "1993" "volumen" => "27" "paginaInicial" => "337" "paginaFinal" => "343" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8453174" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A method for establishing the probability of adverse drug reactions" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C.A. Naranjo" 1 => "U. Busto" 2 => "E.M. Sellers" 3 => "P. Sandor" 4 => "I. Ruiz" 5 => "E.A. Roberts" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Pharmacol Ther" "fecha" => "1981" "volumen" => "30" "paginaInicial" => "239" "paginaFinal" => "245" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7249508" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticonvulsant hypersensitivity syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Kaminsky" 1 => "M. Moreno" 2 => "M. Diaz" 3 => "V. Charas" 4 => "G. Bravo" 5 => "C. Kien" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-4632.2004.02233.x" "Revista" => array:6 [ "tituloSerie" => "Int J Dermatol" "fecha" => "2005" "volumen" => "44" "paginaInicial" => "594" "paginaFinal" => "598" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15985033" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack123025" "titulo" => "Acknowledgment" "texto" => "This work was supported by Dong-A University research fund." "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/03010546/0000004300000001/v1_201501250943/S0301054613002772/v1_201501250943/en/main.assets" "Apartado" => array:4 [ "identificador" => "5554" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/03010546/0000004300000001/v1_201501250943/S0301054613002772/v1_201501250943/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054613002772?idApp=UINPBA00004N"]

Statistics

Original Article

Y.H. Nama, M.R. Parka, H.J. Namb, S.K. Leea,

Corresponding author

skleeai@dau.ac.kr

Corresponding author.

, K.H. Kimc, M.S. Rohd, S.-J. Uma, C.-H. Sona

a Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Republic of Korea

b Department of Pharmacy, Dong-A University Hospital, Busan, Republic of Korea

c Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea

d Department of Pathology, College of Medicine, Dong-A University, Busan, Republic of Korea

Read

4369

Times
was read the article

1014

Total PDF

3355

Total HTML

Share statistics

 array:22 [
  "pii" => "S0301054613002772"
  "issn" => "03010546"
  "doi" => "10.1016/j.aller.2013.08.003"
  "estado" => "S300"
  "fechaPublicacion" => "2015-01-01"
  "aid" => "567"
  "copyright" => "SEICAP"
  "copyrightAnyo" => "2013"
  "documento" => "article"
  "subdocumento" => "fla"
  "cita" => "Allergol  Immunopathol &#40;Madr&#41;. 2015;43:19-24"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 955
    "formatos" => array:3 [
      "EPUB" => 13
      "HTML" => 550
      "PDF" => 392
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "S0301054614000287"
    "issn" => "03010546"
    "doi" => "10.1016/j.aller.2013.10.006"
    "estado" => "S300"
    "fechaPublicacion" => "2015-01-01"
    "aid" => "592"
    "copyright" => "SEICAP"
    "documento" => "article"
    "subdocumento" => "fla"
    "cita" => "Allergol  Immunopathol &#40;Madr&#41;. 2015;43:25-31"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 808
      "formatos" => array:3 [
        "EPUB" => 9
        "HTML" => 349
        "PDF" => 450
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "25"
          "paginaFinal" => "31"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "N. Santos, A.M. Pereira, R. Silva, J. Torres da Costa, J.L. Plácido"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "N."
              "apellidos" => "Santos"
            ]
            1 => array:2 [
              "nombre" => "A.M."
              "apellidos" => "Pereira"
            ]
            2 => array:2 [
              "nombre" => "R."
              "apellidos" => "Silva"
            ]
            3 => array:2 [
              "nombre" => "J."
              "apellidos" => "Torres da Costa"
            ]
            4 => array:2 [
              "nombre" => "J.L."
              "apellidos" => "Plácido"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054614000287?idApp=UINPBA00004N"
    "url" => "/03010546/0000004300000001/v1_201501250943/S0301054614000287/v1_201501250943/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "S0301054614000172"
    "issn" => "03010546"
    "doi" => "10.1016/j.aller.2013.11.002"
    "estado" => "S300"
    "fechaPublicacion" => "2015-01-01"
    "aid" => "581"
    "copyright" => "SEICAP"
    "documento" => "article"
    "subdocumento" => "fla"
    "cita" => "Allergol  Immunopathol &#40;Madr&#41;. 2015;43:14-8"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 1032
      "formatos" => array:3 [
        "EPUB" => 12
        "HTML" => 699
        "PDF" => 321
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "A human monoclonal anti-TNF alpha antibody (adalimumab) reduces airway inflammation and ameliorates lung histology in a murine model of acute asthma"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "14"
          "paginaFinal" => "18"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1385
              "Ancho" => 2100
              "Tamanyo" => 625015
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">(1a and 1b) Normal alveoli and bronchi (control group), H&#38;E &times;40 and &times;100. (2a) Peri-bronchiolar and perivascular mix inflammation (asthma group), H&#38;E &times;40. (2b) Thickened alveolar walls with inflammation (asthma group), H&#38;E &times;100. (3a) The lung parenchyma without inflammation (adalimumab-treated group), H&#38;E &times;40. (3b) Mild thickened alveolar septa (adalimumab-treated group), H&#38;E &times;100.</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "F. Catal, E. Mete, C. Tayman, E. Topal, A. Albayrak, H. Sert"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "F."
              "apellidos" => "Catal"
            ]
            1 => array:2 [
              "nombre" => "E."
              "apellidos" => "Mete"
            ]
            2 => array:2 [
              "nombre" => "C."
              "apellidos" => "Tayman"
            ]
            3 => array:2 [
              "nombre" => "E."
              "apellidos" => "Topal"
            ]
            4 => array:2 [
              "nombre" => "A."
              "apellidos" => "Albayrak"
            ]
            5 => array:2 [
              "nombre" => "H."
              "apellidos" => "Sert"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054614000172?idApp=UINPBA00004N"
    "url" => "/03010546/0000004300000001/v1_201501250943/S0301054614000172/v1_201501250943/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
    "titulo" => "Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "19"
        "paginaFinal" => "24"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Y.H. Nam, M.R. Park, H.J. Nam, S.K. Lee, K.H. Kim, M.S. Roh, S.-J. Um, C.-H. Son"
        "autores" => array:8 [
          0 => array:3 [
            "nombre" => "Y.H."
            "apellidos" => "Nam"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "M.R."
            "apellidos" => "Park"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "H.J."
            "apellidos" => "Nam"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:4 [
            "nombre" => "S.K."
            "apellidos" => "Lee"
            "email" => array:1 [
              0 => "skleeai@dau.ac.kr"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "K.H."
            "apellidos" => "Kim"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "M.S."
            "apellidos" => "Roh"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "S.-J."
            "apellidos" => "Um"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "C.-H."
            "apellidos" => "Son"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:4 [
          0 => array:3 [
            "entidad" => "Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Republic of Korea"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Department of Pharmacy, Dong-A University Hospital, Busan, Republic of Korea"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Department of Dermatology, College of Medicine, Dong-A University, Busan, Republic of Korea"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Department of Pathology, College of Medicine, Dong-A University, Busan, Republic of Korea"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author."
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1141
            "Ancho" => 1706
            "Tamanyo" => 93573
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Frequency of causative drugs of the study subjects.</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a serious drug-induced adverse reaction with a relatively long latency period. The major clinical manifestations are fever, skin rash, and the involvement of several internal organs. Various names have been used to describe this single disease<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1&#8211;5</span></a>; this reflects the difficulties in defining the disorder and in clarifying its diagnostic criteria. Recently, the European Registry of Severe Cutaneous Adverse Reactions (RegiSCAR), a study group dedicated to investigating such reactions, has introduced the term hypersensitivity syndrome (HSS)/DRESS.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> We consider HSS/DRESS to be more compatible, because this term includes elements of the pathogenesis, aetiology and clinical features.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Originally, HSS/DRESS was first described in subjects who had been prescribed the anticonvulsant, phenytoin.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Other drugs which have been well known as causes include carbamazepine, allopurinol, sulfasalazine, phenobarbital, lamotrigine, and nevirapine.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Antibiotics,<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> non-steroidal anti-inflammatory drugs (NSAIDs),<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> and antituberculosis drugs<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> have been reported sporadically as causative drugs in the form of case reports. In addition, several new drugs have increasingly been reported as new causative agents for HSS/DRESS development.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The other noteworthy feature of HSS/DRESS is a delayed onset usually 2&#8211;6 weeks after the initiation of drug therapy.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> This finding can be compatible to many traditional causative drugs, which includes anticonvulsants and antituberculosis drugs.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,9</span></a> However, after careful review of case reports including those of antibiotics, there have been some causative drugs which have had a relatively short latency period of less than two weeks.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9&#8211;14</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Early withdrawal of the offending drug and administration of systemic corticosteroids (SCS) has been regarded as the most important step in the treatment of this disease.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> More than 50% of study subjects were treated with SCS.<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">16&#8211;19</span></a> However, randomised controlled trials are lacking, and whether SCS should be administered remains controversial.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">We report clinical features of 45 subjects with HSS/DRESS in a single tertiary referral centre for two years, in which we describe the characteristics of causative agents, including latency period and clinical outcomes.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Materials and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Subjects</span><p id="par0030" class="elsevierStylePara elsevierViewall">We conducted a retrospective analysis of prospectively collected data of 45 patients with HSS/DRESS syndrome, who were diagnosed between September 2009 and August 2011 in a tertiary referral centre. The clinical characteristics and courses of the patients were evaluated. This study was approved by the institutional review board of Dong-A University Hospital.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Diagnostic criteria</span><p id="par0035" class="elsevierStylePara elsevierViewall">Patients with HSS/DRESS were defined as described previously,<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> which was modified from other reports.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,20,21</span></a> This included: acute skin rash; fever of more than 38<span class="elsevierStyleHsp" style=""></span>&deg;C in a patient after taking a specific drug; at least one of the following internal organ abnormalities: lymphadenopathy at a minimum of two sites, hepatitis, nephritis, and/or pneumonitis, haematological abnormalities with eosinophilia (defined as more than 10% of total white blood cells or over 500<span class="elsevierStyleHsp" style=""></span>cells/¿L), the presence of atypical lymphocytes, thrombocytopenia and/or leucopoenia. The involvement of the liver and kidney was defined by a twofold increase of liver enzymes over the normal value, and the new onset of an abnormal urinalysis with haematuria and/or proteinuria, an increasing serum creatinine above the normal range and a deterioration of pre-existing chronic renal insufficiency. Pulmonary involvement was considered when abnormal findings on chest radiographs were presented with either an increased sputum eosinophil count, improvement with SCS, or spontaneously. Central nervous system (CNS) involvement was considered when abnormal mental status was combined with radiological abnormalities in magnetic resonance imaging (MRI) and improvement after treatment with SCS. Additionally, we incorporated the RegiSCAR&#39;s<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> scoring system to grade HSS/DRESS cases as &#8220;no&#8221;, &#8220;possible&#8221;, &#8220;probable&#8221;, or &#8220;definite&#8221;.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Cases of typical manifestations of Stevens&#8211;Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) were excluded. Culprit drugs were determined by reviewing medication histories and clinical courses which showed improvements of skin rash and other systemic symptoms after discontinuation of the suspected drug.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Laboratory studies</span><p id="par0045" class="elsevierStylePara elsevierViewall">Complete blood cell counts, serum biochemistry including liver and renal function tests, and urinalyses were performed. Serological tests for autoimmune antibodies such as antinuclear antibodies and anti-DNA antibodies, and several viral antibodies, including herpes simplex virus, cytomegalovirus, Epstein&#8211;Barr virus, HIV, and hepatitis A, B, and C viruses, were performed in order to rule out other autoimmune or viral diseases.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Statistical analyses</span><p id="par0050" class="elsevierStylePara elsevierViewall">Quantitative and qualitative results are given by the means<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>SD and absolute numbers or frequencies, respectively. Descriptive statistics were performed using SPSS software (ver. 15.0; SPSS Inc., Chicago, IL, USA). We used laboratory values that were the highest values during the clinical course. Comparisons of various laboratory results were performed using the Mann&#8211;Whitney <span class="elsevierStyleItalic">U</span> and Kruskal&#8211;Wallis tests. Correlations between various clinical parameters were evaluated with the Pearson&#39;s correlation coefficient. <span class="elsevierStyleItalic">P</span> values<span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0.05 were considered to indicate statistical significance.</p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Results</span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Clinical characteristics of study subjects</span><p id="par0055" class="elsevierStylePara elsevierViewall">A total of 45 patients (19 males) who were diagnosed as having HSS/DRESS were included in this study. The mean age of the patients was 57.6<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>15.7 years (range, 26&#8211;86) (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Among 45 study patients 26 (57.8%) were referred from adjacent primary or secondary care hospitals. Twenty-eight patients (62.2%) were treated in the department of internal medicine and others were consulted from various surgical departments. The mean point according to RegiSCAR criteria was 4.4<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>1.36 points (range, 2&#8211;7) (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Subjects were classified as definite 13 (28.9%), probable 19 (42.2%), and possible 13 (28.9%) HSS/DRESS cases, respectively, and none of the subjects were compatible with &#8220;no&#8221;.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Causative drugs</span><p id="par0060" class="elsevierStylePara elsevierViewall">The most common causative drug group was antibiotics (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>13, 28.9%), followed by anticonvulsants (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>12, 26.7%), antituberculosis drugs (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6, 13.3%), NSAIDs (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4, 8.9%), undetermined (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4, 8.9%), allopurinol (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3, 6.7%) and others (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3, 6.7%) (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Causative antibiotics included cephalosporins, penicillins, moxifloxacin and vancomycin. Anticonvulsants included carbamazepine, phenobarbital, phenytoin, lamotrigine and topiramate. NSAIDs were diclofenac and celecoxib (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Antituberculosis drugs were isoniazid, rifampin, ethambutol, pyrazinamide (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>). Four cases were classified as undetermined due to the concomitant use of multiple drugs, while the remaining three cases were classified as &#8220;others&#8221; due to the use of anti-cancer, iron-chelating and proton-pump inhibitors (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Latency period</span><p id="par0065" class="elsevierStylePara elsevierViewall">The latency period between the administration of causative drugs and the development of the manifestation of HSS/DRESS ranged from 2 to 120 days, with a mean of 20.2<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>24.3 days (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). The antituberculosis group had the longest latency period, 46.5<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>29.9 days (range, 24&#8211;100 days), followed by anticonvulsants with 31.1<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>31.2 days (range, 5&#8211;120 days). The latency period for antibiotics was 7.8<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>8.0 days (range, 2&#8211;28 days). A statistical significance was noted between anticonvulsants and antibiotics, as well as antituberculosis and antibiotics (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0.05, respectively) (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Laboratory results</span><p id="par0070" class="elsevierStylePara elsevierViewall">Haematological abnormalities were found to include eosinophilia in 35 patients (77.8%), in addition to atypical lymphocytosis (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>16, 35.6%) and thrombocytopenia (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>7, 15.6%). All patients had involvement of at least one internal organ. Liver was the most frequently involved organ (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>39, 86.7%), followed by kidney (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>8, 17.8%), lung (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4, 8.9%) and CNS (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1, 2.3%) (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). None of the patients had positive findings for autoimmune antibodies or IgM antibodies to viruses.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Treatment outcome</span><p id="par0075" class="elsevierStylePara elsevierViewall">Thirty-five patients (77.8%) were treated conservatively with topical steroids and antihistamines, while 10 patients (22.2%) were treated with SCS. The mean<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>SD time of admission in patients with SCS was 46.0<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>30.1 days (range, 11&#8211;111 days), and 18.4<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>11.7 days (range, 3&#8211;54 days) in patients with conservative treatment. Statistically significant differences were noted between the two groups (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0.05). Most of the patients showed good clinical outcomes. Forty-three patients (95.6%) recovered completely. However, one patient died due to sepsis arising from long-term high-dose SCS treatment, and another patient had progressive hepatic failure, and was referred to another hospital in a remote region.</p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Discussion</span><p id="par0080" class="elsevierStylePara elsevierViewall">This study is a retrospective analysis of prospectively collected data of 45 patients with HSS/DRESS in a tertiary referral hospital over a period of two years. The prevalence of HSS/DRESS was more common than had been generally recognised, and the causative drugs were quite variable. In particular, antibiotics and NSAIDs as well as antituberculosis drugs appeared to be major causes of HSS/DRESS. Antibiotics showed relatively short incubation periods (less than two weeks), and seemingly better clinical courses. Most of the study subjects (95.6%) showed better clinical outcomes than had been expected.</p><p id="par0085" class="elsevierStylePara elsevierViewall">The estimated incidence of HSS/DRESS was 1 in 1000&#8211;10,000 drug exposures.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a> In a referral centre hospital, the prevalence was reported approximately as 6&#8211;8 patients per year.<span class="elsevierStyleSup">(</span><a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,16,17,19</span></a><span class="elsevierStyleSup">)</span> The incidence of HSS/DRESS in this study was relatively high, at 45 patients during a two-year period in one tertiary referral centre. We believe that several factors have contributed to our findings. First, we implemented an adverse drug reaction surveillance system in our hospital, by which anyone involved in patient care was able to report any adverse drug reaction through a computerised communication system to a surveillance centre. Two medical doctors and one pharmacist evaluated adverse drug reactions and attempted to identify the causative drugs with an authorised algorithm. Second, any adverse drug reactions were usually followed up for some time until the patient showed an improvement. Some reactions were initially regarded as simple exanthematous drug eruptions, but conditions that progressed were ultimately diagnosed as HSS/DRESS, especially among the antibiotics group. Other reactions were defined initially as simple drug eruptions by doctors who were not familiar with HSS/DRESS, but were ultimately defined as HSS/DRESS. Finally, these data were collected from a tertiary referral centre located in the south-eastern part of South Korea, serving a region of more than three million inhabitants. More than 50% of study subjects were referred from primary or secondary care hospitals. These factors may explain the higher incidence in this study compared to previously published studies.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,16,17,19</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">One prominent result of this study was the finding that the most common causative drug group of HSS/DRESS was antibiotics, recognised as the causative agent for 13 patients (28.9%). This figure was relatively higher than a recent retrospective study which identified antibiotics as being the causative agent in 6 of 60 patients (10%).<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> This result may have originated from the misconception that HSS/DRESS could develop after the administration of anticonvulsants and allopurinol, and that HSS/DRESS caused by antibiotics showed a relatively milder course than any other causative drugs. Furthermore, incorrect diagnosis as a simple drug eruption by doctors who were not familiar with HSS/DRESS have also likely played a role in prior studies which have observed lower numbers of HSS/DRESS due to antibiotics.</p><p id="par0095" class="elsevierStylePara elsevierViewall">We think traditional culprit drugs, for example anticonvulsants and allopurinol, have higher risk than other drugs. However, our results also postulated that non-traditional causative drugs, for example antibiotics, antituberculosis and NSAIDs can cause HSS/DRESS. More attention should be paid to these non-traditional causative drugs, as new causative drugs of HSS/DRESS.</p><p id="par0100" class="elsevierStylePara elsevierViewall">A delayed onset of symptoms by 2&#8211;6 weeks after the initiation of the causative drug is a feature of HSS/DRESS.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> In this study, the incubation time of the antibiotics group showed a significantly shorter duration than that of the anticonvulsants or antituberculosis group (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>). This phenomenon can be found in other reports of HSS/DRESS caused by antibiotics.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9&#8211;14</span></a> We cannot explain this finding accurately, but it is likely that this occurs due to different drug metabolisms and variable individual sensitivity to metabolites of antibiotics. It is possible that a long latency period is adequate for some drugs, especially anticonvulsants. We believe that latency periods may be variable according to each culprit drug.</p><p id="par0105" class="elsevierStylePara elsevierViewall">At present, HSS/DRESS is generally treated with moderate- or high-dose SCS, but response may be suboptimal and can result in a prolonged exposure to SCS.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> A recent retrospective analysis showed that 75% of study subjects were treated with SCS, and that the death rate was 10%.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> In this study, SCS was administered to only 10 patients (22.0%), and the remaining 35 patients (77.8%) were treated conservatively without SCS. Furthermore, the proportion of complete recovery was 95.6%, and seemed higher than that of previous reports. A significant difference was noted in the number of admission days of SCS treated and conservatively treated group. However, the data were insufficient for direct comparison with previous published results, because there was a discrepancy in the composition of study patients, as well as in the culprit drugs.</p><p id="par0110" class="elsevierStylePara elsevierViewall">This study has several limitations. First, the culprit drugs were determined based on subjective clinical decisions, and not with objective methods such as lymphocyte toxicity assay or LTT. Second, evaluations to find out the association between viral reactivation and HSS/DRESS development should have been performed but were not.</p><p id="par0115" class="elsevierStylePara elsevierViewall">In conclusion, drugs associated with HSS/DRESS were variable, and attention should be paid to many new causative drugs, especially antibiotics and NSAIDs. HSS/DRESS was not more uncommon than generally recognised, and most patients with this disease showed better clinical outcomes than might have been generally expected based on previous findings.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Ethical disclosures</span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Patients&#8217; data protection</span><p id="par0120" class="elsevierStylePara elsevierViewall">Confidentiality of data. The authors declare that they have followed the protocols of their work centre on the publication of patient data and that all the patients included in the study have received sufficient information and have given their informed consent in writing to participate in that study.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Right to privacy and informed consent</span><p id="par0125" class="elsevierStylePara elsevierViewall">The authors have obtained the informed consent of the patients and/or subjects mentioned in the article. The author for correspondence is in possession of this document.</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Protection of human subjects and animals in research</span><p id="par0130" class="elsevierStylePara elsevierViewall">The authors declare that no experiments were performed on humans or animals for this investigation.</p></span></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conflict of interest</span><p id="par0135" class="elsevierStylePara elsevierViewall">All authors have no conflicts of interest in this study. The authors alone are responsible for content and the writing of the paper.</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:10 [
        0 => array:2 [
          "identificador" => "xres414307"
          "titulo" => array:5 [
            0 => "Abstract"
            1 => "Background"
            2 => "Methods"
            3 => "Results"
            4 => "Conclusions"
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec389947"
          "titulo" => "Keywords"
        ]
        2 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Introduction"
        ]
        3 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Materials and methods"
          "secciones" => array:4 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Subjects"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Diagnostic criteria"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Laboratory studies"
            ]
            3 => array:2 [
              "identificador" => "sec0030"
              "titulo" => "Statistical analyses"
            ]
          ]
        ]
        4 => array:3 [
          "identificador" => "sec0035"
          "titulo" => "Results"
          "secciones" => array:5 [
            0 => array:2 [
              "identificador" => "sec0040"
              "titulo" => "Clinical characteristics of study subjects"
            ]
            1 => array:2 [
              "identificador" => "sec0045"
              "titulo" => "Causative drugs"
            ]
            2 => array:2 [
              "identificador" => "sec0050"
              "titulo" => "Latency period"
            ]
            3 => array:2 [
              "identificador" => "sec0055"
              "titulo" => "Laboratory results"
            ]
            4 => array:2 [
              "identificador" => "sec0060"
              "titulo" => "Treatment outcome"
            ]
          ]
        ]
        5 => array:2 [
          "identificador" => "sec0065"
          "titulo" => "Discussion"
        ]
        6 => array:3 [
          "identificador" => "sec0070"
          "titulo" => "Ethical disclosures"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0075"
              "titulo" => "Patients&#8217; data protection"
            ]
            1 => array:2 [
              "identificador" => "sec0080"
              "titulo" => "Right to privacy and informed consent"
            ]
            2 => array:2 [
              "identificador" => "sec0085"
              "titulo" => "Protection of human subjects and animals in research"
            ]
          ]
        ]
        7 => array:2 [
          "identificador" => "sec0090"
          "titulo" => "Conflict of interest"
        ]
        8 => array:2 [
          "identificador" => "xack123025"
          "titulo" => "Acknowledgment"
        ]
        9 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2013-05-30"
    "fechaAceptado" => "2013-08-07"
    "PalabrasClave" => array:1 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec389947"
          "palabras" => array:3 [
            0 => "Anticonvulsants"
            1 => "Drug hypersensitivity"
            2 => "Eosinophilia"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:1 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare disease which can cause severe morbidity and mortality. The aim of this study is to evaluate the clinical manifestation and course of DRESS syndrome.</p> <span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We conducted a retrospective analysis of prospectively collected data in 45 patients with DRESS syndrome diagnosed between September 2009 and August 2011.</p> <span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The most common causative drug group was antibiotics (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>13, 28.9%), followed by anticonvulsants (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>12, 26.7%), antituberculosis drugs (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6, 13.3%), non-steroidal anti-inflammatory drugs (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4, 8.9%), undetermined agents (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4, 8.9%), allopurinol (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3, 6.7%), and others (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3, 6.7%). The latency period ranged from 2 to 120 days, with a mean of 20.2<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>24.3 days. The longest latency period was noted for the antituberculosis drug group, at 46.5<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>29.9 days. Eosinophilia in peripheral blood examination was noted in 35 subjects (77.8%). Atypical lymphocytosis was noted in 16 patients (35.6%), and thrombocytopenia in seven patients (15.6%). Hepatic involvement was noted in 39 (86.7%) study patients, kidney in eight (17.8%), lung in four (8.9%), and central nervous system in one (2.3%). Systemic corticosteroids were administered to 10 patients (22.2%). Forty-three patients (95.6%) showed complete recovery, while two patients had poor outcomes.</p> <span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">DRESS syndrome was not more uncommon than generally recognised. Antibiotics were the most frequently implicated drug group, followed by anticonvulsants. Most patients with this disease showed a better clinical outcome than that which had been generally expected.</p>"
      ]
    ]
    "multimedia" => array:6 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1141
            "Ancho" => 1706
            "Tamanyo" => 93573
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Frequency of causative drugs of the study subjects.</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1156
            "Ancho" => 1666
            "Tamanyo" => 57694
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Incubation days according to the causative drugs. There was a statistically significant difference between the anticonvulsants and antibiotics group (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0.05), and among the antibiotics and antituberculosis groups (<span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0.05) respectively.</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:3 [
          "leyenda" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">GOT. aspartate aminotransferase; GPT, alanine aminotransferase; TB, total bilirubin; DB, direct bilirubin.</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Characteristics&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>45 (% or range)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Sex, male</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">19 (42.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Age (years)</span><a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">57.6<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>15.7 (26, 86)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Admission (days)</span><a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">24.5<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>20.6 (3, 111)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Incubation (days)</span><a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">20.2<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>24.3 (2, 120)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Eosinophils (cells/¿L)</span><a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2566.0<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>3129.5 (62, 13,296)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Atypical lymphocytosis (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">16 (35.6)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Thrombocytopenia (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">7 (15.6)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Hepatitis (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">39 (86.7)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>GOT<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">214.4<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>335.0 (12, 1831)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>GPT<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">224.1<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>290.4 (8, 1482)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>TB<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1.6<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>3.3 (0.3, 18.0)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>DB<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1.0<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>2.1 (0.1, 10.3)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Nephritis (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">8 (17.8)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Pneumonitis (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4 (8.9)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Central nervous system (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">1 (2.3)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Systemic corticosteroids use (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">10 (22.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Recurrence (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5 (11.1)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Poor prognosis (%)</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">2 (4.4)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleItalic">Diagnostic score</span><a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">4.4<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>1.4 (2, 7)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab646877.png"
              ]
            ]
          ]
          "notaPie" => array:2 [
            0 => array:3 [
              "identificador" => "tblfn0005"
              "etiqueta" => "a"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Data presented as mean<span class="elsevierStyleHsp" style=""></span>&plusmn;<span class="elsevierStyleHsp" style=""></span>SD of 45 study patients.</p>"
            ]
            1 => array:3 [
              "identificador" => "tblfn0010"
              "etiqueta" => "b"
              "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Diagnostic score by RegiSCAR.</p>"
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Clinical characteristics of the study patients.</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "tbl0010"
        "etiqueta" => "Table 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">NSAIDs; non-steroidal anti-inflammatory drugs.</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Group&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">n</span> (%)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleBold">Antibiotics</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">13 (28.9)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Cephalosporins</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">7 (15.6)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Ceftriaxone&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3 (6.7)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Cefotaxime&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Ceftezol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Cefaclor&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Flumarin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Penicillin</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4 (8.9)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Tazocin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2 (4.4)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Nafcillin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Amoxicillin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Moxifloxacin</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Vancomycin</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleBold">Anticonvulsants</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">12 (26.7)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Carbamazepine</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4 (8.9)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Phenobarbital</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3 (6.7)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Phenytoin</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2 (4.4)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Lamotrigine</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">2 (4.4)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Topiramate</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1 (2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleBold">NSAIDs</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">4 (8.9)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Diclofenac</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">3 (6.7)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Celecoxib</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="char" valign="top">1(2.2)&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab646874.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Causative drugs of antibiotics, anticonvulsant and NSAIDs groups.</p>"
        ]
      ]
      4 => array:7 [
        "identificador" => "tbl0015"
        "etiqueta" => "Table 3"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">F, female; M, male.</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Number of patients&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age/Sex&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Disease&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Drugs&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">71/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Urethral tuberculosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Isoniazid, rifampin, ethambutol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">86/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pulmonary tuberculosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ethambutol, pyrazinamide&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">78/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pulmonary tuberculosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">isoniazid&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">45/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pulmonary tuberculosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Isoniazid, rifampin, pyrazinamide&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">69/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pulmonary tuberculosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Rifampin, ethambutol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">74/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pulmonary tuberculosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Rifampin, ethambutol&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab646875.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Clinical characteristics of six patients who had antituberculosis drugs as culprit drugs.</p>"
        ]
      ]
      5 => array:7 [
        "identificador" => "tbl0020"
        "etiqueta" => "Table 4"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Numbers 1&#8211;4 include patients with undetermined causative drugs.</p><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">F, female; M, male.</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Number of patients&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Age/Sex&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Disease&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Drugs&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">65/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pneumonia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ceftriaxone, ibuprofen&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">43/M&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Bronchitis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ceftezol, dicofenac&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">70/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pneumonia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Cefixime, diclofenac&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">68/M&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Pneumonia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ceftriaxone, phenytoin&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">5&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">66/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Colon cancer&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">5-fluorouracil&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">6&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">38/M&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Leukaemia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Desferasirox<span class="elsevierStyleSup">a</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="char" valign="top">7&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">61/F&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Peptic ulcer&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Rabeprazol<span class="elsevierStyleSup">b</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab646876.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Clinical characteristics of four patients who had undetermined drugs, and three with other culprit drugs.</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:23 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S.A. Walsh"
                            1 => "D. Creamer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2230.2010.03967.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Exp Dermatol"
                        "fecha" => "2011"
                        "volumen" => "36"
                        "paginaInicial" => "6"
                        "paginaFinal" => "11"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21143513"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "T. Shiohara"
                            1 => "M. Iijima"
                            2 => "Z. Ikeazwa"
                            3 => "K. Hashimoto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2133.2007.07807.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2007"
                        "volumen" => "156"
                        "paginaInicial" => "1083"
                        "paginaFinal" => "1084"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17381452"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "H. Bocquet"
                            1 => "M. Bagot"
                            2 => "J.C. Roujeau"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Semin Cutan Med Surg"
                        "fecha" => "1996"
                        "volumen" => "5"
                        "paginaInicial" => "250"
                        "paginaFinal" => "257"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R.D. Sontheimer"
                            1 => "K.R. Houpt"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "1998"
                        "volumen" => "134"
                        "paginaInicial" => "874"
                        "paginaFinal" => "876"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9681358"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The DRESS syndrome: a literature review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P. Cacoub"
                            1 => "P. Musette"
                            2 => "V. Descamps"
                            3 => "O. Meyer"
                            4 => "C. Speirs"
                            5 => "L. Finzi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.amjmed.2011.01.017"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "2011"
                        "volumen" => "124"
                        "paginaInicial" => "588"
                        "paginaFinal" => "597"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21592453"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S.H. Kardaun"
                            1 => "A. Sidoroff"
                            2 => "L. Valeyrie-Allanore"
                            3 => "S. Halevy"
                            4 => "B.B. Davidovici"
                            5 => "M. Mockenhaupt"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2133.2006.07704.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2007"
                        "volumen" => "156"
                        "paginaInicial" => "609"
                        "paginaFinal" => "611"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17300272"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of epilepsy with sodium diphenyl hydantoine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R. Coope"
                            1 => "R. Burrows"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "1940"
                        "volumen" => "1"
                        "paginaInicial" => "490"
                        "paginaFinal" => "492"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2563853"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antituberculosis drug-induced drug rash with eosinophilia and systemic symptoms syndrome confirmed by patch testing"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S.W. Lee"
                            1 => "N.B. Yoon"
                            2 => "S.M. Park"
                            3 => "S.M. Lee"
                            4 => "S.J. Um"
                            5 => "S.K. Lee"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Investig Allergol Clin Immunol"
                        "fecha" => "2010"
                        "volumen" => "20"
                        "paginaInicial" => "620"
                        "paginaFinal" => "632"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21314006"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical features of drug-induced hypersensitivity syndrome in 38 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S.J. Um"
                            1 => "S.K. Lee"
                            2 => "Y.H. Kim"
                            3 => "K.H. Kim"
                            4 => "C.H. Son"
                            5 => "M.S. Roh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Investig Allergol Clin Immunol"
                        "fecha" => "2010"
                        "volumen" => "20"
                        "paginaInicial" => "556"
                        "paginaFinal" => "562"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21313995"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Moxifloxacine-associated drug hypersensitivity syndrome with drug-induced hypersensitivity pneumonitis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C.H. Son"
                            1 => "H.I. Kim"
                            2 => "K.N. Kim"
                            3 => "K.N. Lee"
                            4 => "C.U. Lee"
                            5 => "M.S. Roh"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Investig Allergol Clin Immunol"
                        "fecha" => "2008"
                        "volumen" => "18"
                        "paginaInicial" => "72"
                        "paginaFinal" => "73"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18361108"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lenezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "S. Savard"
                            1 => "S. Desmeules"
                            2 => "J. Riopel"
                            3 => "M. Aqharazii"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.ajkd.2009.07.013"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Kidney Dis"
                        "fecha" => "2009"
                        "volumen" => "54"
                        "paginaInicial" => "e17"
                        "paginaFinal" => "e20"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19733945"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Vancomycin-induced DRESS syndrome in a female patient"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L. Vauthey"
                            1 => "I. Uckay"
                            2 => "S. Abrassart"
                            3 => "L. Bernard"
                            4 => "M. Assal"
                            5 => "T. Ferry"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1159/000142729"
                      "Revista" => array:6 [
                        "tituloSerie" => "Pharmacology"
                        "fecha" => "2008"
                        "volumen" => "82"
                        "paginaInicial" => "138"
                        "paginaFinal" => "141"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18607115"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "R. Tamagawa-Mineoka"
                            1 => "N. Katoh"
                            2 => "T. Nara"
                            3 => "Y. Nishimura"
                            4 => "S. Yamato"
                            5 => "S. Kishinoto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-4632.2007.03255.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Dermatol"
                        "fecha" => "2007"
                        "volumen" => "46"
                        "paginaInicial" => "654"
                        "paginaFinal" => "655"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17550572"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A case of cephalosporin-induced DRESS (drug rash with eosinophilia and systemic symptoms) syndrome with acute renal failure"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C.M. Ahn"
                            1 => "J.H. Moon"
                            2 => "J.G. Moon"
                            3 => "K.M. Lee"
                            4 => "J.H. Lee"
                            5 => "C.S. Hong"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Korean J Asthma Allergy Clin Immunol"
                        "fecha" => "2005"
                        "volumen" => "25"
                        "paginaInicial" => "69"
                        "paginaFinal" => "72"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S. Tas"
                            1 => "T. Simonart"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "69956"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dermatology"
                        "fecha" => "2003"
                        "volumen" => "206"
                        "paginaInicial" => "353"
                        "paginaFinal" => "356"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12771485"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C.C. Chiou"
                            1 => "L.C. Yang"
                            2 => "S.I. Hung"
                            3 => "Y.C. Chang"
                            4 => "T.T. Kuo"
                            5 => "Y.C. Chang"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1468-3083.2008.02585.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol"
                        "fecha" => "2008"
                        "volumen" => "22"
                        "paginaInicial" => "1044"
                        "paginaFinal" => "1049"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18627428"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M. Ben m&#8217;rad"
                            1 => "S. Leclerc-Mercier"
                            2 => "P. Blanche"
                            3 => "N. Franck"
                            4 => "F. Rozenberg"
                            5 => "Y. Fulla"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Medicine (Baltimore)"
                        "fecha" => "2009"
                        "volumen" => "88"
                        "paginaInicial" => "131"
                        "paginaFinal" => "140"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M. Eshki"
                            1 => "L. Allanore"
                            2 => "P. Musette"
                            3 => "B. Milpied"
                            4 => "A. Grange"
                            5 => "J.C. Guillaume"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archderm.145.1.67"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "2009"
                        "volumen" => "145"
                        "paginaInicial" => "67"
                        "paginaFinal" => "72"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19153346"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "Y.C. Chen"
                            1 => "H.C. Chiu"
                            2 => "C.Y. Chu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1001/archdermatol.2010.198"
                      "Revista" => array:6 [
                        "tituloSerie" => "Arch Dermatol"
                        "fecha" => "2010"
                        "volumen" => "146"
                        "paginaInicial" => "1373"
                        "paginaFinal" => "1379"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20713773"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical heterogeneity of drug hypersensitivity"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J.C. Roujeau"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.tox.2004.12.022"
                      "Revista" => array:6 [
                        "tituloSerie" => "Toxicology"
                        "fecha" => "2005"
                        "volumen" => "209"
                        "paginaInicial" => "123"
                        "paginaFinal" => "129"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15767024"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib0105"
              "etiqueta" => "21"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Allopurinol hypersensitivity syndrome: a review"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "F. Arellano"
                            1 => "J.A. Sacristan"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Pharmacother"
                        "fecha" => "1993"
                        "volumen" => "27"
                        "paginaInicial" => "337"
                        "paginaFinal" => "343"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8453174"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib0110"
              "etiqueta" => "22"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "A method for establishing the probability of adverse drug reactions"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C.A. Naranjo"
                            1 => "U. Busto"
                            2 => "E.M. Sellers"
                            3 => "P. Sandor"
                            4 => "I. Ruiz"
                            5 => "E.A. Roberts"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Clin Pharmacol Ther"
                        "fecha" => "1981"
                        "volumen" => "30"
                        "paginaInicial" => "239"
                        "paginaFinal" => "245"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7249508"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib0115"
              "etiqueta" => "23"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Anticonvulsant hypersensitivity syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A. Kaminsky"
                            1 => "M. Moreno"
                            2 => "M. Diaz"
                            3 => "V. Charas"
                            4 => "G. Bravo"
                            5 => "C. Kien"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-4632.2004.02233.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Int J Dermatol"
                        "fecha" => "2005"
                        "volumen" => "44"
                        "paginaInicial" => "594"
                        "paginaFinal" => "598"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15985033"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:4 [
        "identificador" => "xack123025"
        "titulo" => "Acknowledgment"
        "texto" => "<p id="par0140" class="elsevierStylePara elsevierViewall">This work was supported by <span class="elsevierStyleGrantSponsor" id="gs0005">Dong-A University research fund</span>.</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/03010546/0000004300000001/v1_201501250943/S0301054613002772/v1_201501250943/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "5554"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Original articles"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/03010546/0000004300000001/v1_201501250943/S0301054613002772/v1_201501250943/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054613002772?idApp=UINPBA00004N"
]

Article information

ISSN: 03010546
Original language: English

DOI:10.1016/j.aller.2013.08.003

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	10	0	10
2024 October	69	8	77
2024 September	76	12	88
2024 August	98	16	114
2024 July	102	18	120
2024 June	75	7	82
2024 May	79	13	92
2024 April	70	10	80
2024 March	97	6	103
2024 February	107	11	118
2024 January	100	16	116
2023 December	108	12	120
2023 November	159	17	176
2023 October	139	20	159
2023 September	91	18	109
2023 August	82	13	95
2023 July	88	13	101
2023 June	67	9	76
2023 May	81	10	91
2023 April	71	8	79
2023 March	68	12	80
2023 February	52	13	65
2023 January	52	11	63
2022 December	54	16	70
2022 November	53	24	77
2022 October	53	10	63
2022 September	56	21	77
2022 August	48	8	56
2022 July	46	13	59
2022 June	56	8	64
2022 May	77	22	99
2022 April	29	16	45
2022 March	27	14	41
2022 February	29	3	32
2022 January	35	4	39
2021 December	22	19	41
2021 November	36	18	54
2021 October	27	11	38
2021 September	27	19	46
2021 August	19	15	34
2021 July	16	11	27
2021 June	23	11	34
2021 May	45	17	62
2021 April	30	15	45
2021 March	17	13	30
2021 February	22	14	36
2021 January	15	7	22
2020 December	2	1	3
2020 August	0	4	4
2020 July	0	1	1
2020 May	0	3	3
2020 April	0	5	5
2020 March	0	2	2
2020 February	0	8	8
2020 January	0	9	9
2019 December	0	1	1
2019 November	0	4	4
2019 September	0	7	7
2019 August	0	6	6
2019 July	0	10	10
2019 June	0	14	14
2019 May	0	37	37
2019 April	0	29	29
2019 March	0	22	22
2019 February	0	2	2
2019 January	0	6	6
2018 March	3	3	6
2018 February	12	3	15
2018 January	11	5	16
2017 December	18	8	26
2017 November	22	9	31
2017 October	23	4	27
2017 September	10	9	19
2017 August	29	13	42
2017 July	22	5	27
2017 June	14	12	26
2017 May	25	7	32
2017 April	19	11	30
2017 March	8	21	29
2017 February	26	2	28
2017 January	14	6	20
2016 December	25	6	31
2016 November	18	6	24
2016 October	37	10	47
2016 September	26	6	32
2016 August	19	5	24
2016 July	23	3	26
2016 June	31	6	37
2016 May	18	10	28
2016 April	15	10	25
2016 March	25	12	37
2016 February	24	10	34
2016 January	26	11	37
2015 October	0	1	1
2015 July	0	1	1
2015 June	0	1	1
2015 May	0	3	3
2015 April	0	5	5
2015 March	1	6	7
2015 February	6	11	17

Show all

Allergologia et Immunopathologia is no longer published on Elsevier since the 2021 year.Transferred to Codon Publications

Indexed in:

Follow us:

Statistics

Allergologia et Immunopathologia is no longer published on Elsevier since the 2021 year.Transferred to Codon Publications

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter